First of all, I have never ever said here, or anywhere else that there is a conspiracy involving drug companies. I have never believed it is a conspiracy, and have stated so before. I would say that I have a much better chance of knowing what I do, and do not believe than someone else. That is purely your own opinion based on zero evidence. You can repeat this as many times as you wish, but it does not make it a fact. If anything it is an example of how a person jumps to conclusions without any evidence, which is precisly what you are accusing me of doing.
Secondly, there is no possible way for you to know what I think. Anymore than I can know what you think. I will be in charge of what I think.
I base my opinions on factual information that is gathered by people who do not have a financial interest in the conclusion. I do not know what you are basing your opinions on. The links below are factual findings that proves that drug companies do in fact skew the conclusions of studies, and exclude unfavorable information. If they do it in some of the trials that are investigated, it is reasonable to assume it is also done in others. The average person has no way of knowing which are legit and which have been spun.
A five minute search would have verified what I was reffering to.
http://tinyurl.com/ddwu6w
http://tinyurl.com/4suwej
http://tinyurl.com/23zvtv
http://tinyurl.com/cgozg8
You can also look up a few of the references listed below. There are many others also.
Kassirer, J.P. On the take: How medicine's complicity with big business can endanger your health. Oxford, UK: Oxford University Press: 2005.; Lesser et al. ‘Relationship between funding source and conclusion among nutrition-related scientific articles’. PLoS Medicine 2007.; Jorgensen AW, Hilden J, Gotzsche PC. Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review. BMJ 2006;333:782-5.;Veronica Yank, Drummond Rennie, Lisa A Bero, Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study BMJ 2007;335:1202-1205 (8 December), doi:10.1136/bmj.39376.447211.BE (published 16 November 2007); Jim Giles, Industry money skews drug overviews Nature 437, 458-459 (22 September 2005); DeAngelis, C. Comment on “Conflict of interest in medical research: facts and friction” in meeting proceedings, call to action: Managing financial relationships between academia and industry in biomedical research 2007; 15-16.;Peppercorn, J, Blood, E., Winer, E, Partridge, A. Association between pharmaceutical involvement and outcomes in breast cancer clinical trials. Presented at the Annual Meeting of the American Society of Clinical Oncology 2005.